TFF3 and survivin expressions associate with a lower survival rate in gastric cancer
- 454 Downloads
Trefoil factor 3 (TFF3) and survivin with functions of inhibiting apoptosis are involved in the gastric cancer by overexpression. The purpose of this study is to examine the expression of TFF3 and survivin in patients’ tissue samples with gastric cancer and analyze the relationship between the protein expression and the different clinical records. By studying the expressions of TFF3 and survivin in gastric cancer through immunohistochemical staining and examining the survival rate via Kaplan–Meier analysis for gastric cancer patients, we found that the TFF3 and survivin positive expressions have a significant relationship with the lower survival rate comparing to that of negative expressions in the analyzed patients (P < 0.05). And moreover, patients with double positive TFF3 and survivin expressions have the lowest survival rate. TFF3 or survivin positive expression correlates with the lymph node metastasis, metastasis, and TNM stages of gastric cancer. Survival analysis indicates that survival rate has a close relationship with the age, tumor histology, tumor differentiation, degree of infiltration, lymph node metastasis, distant metastasis, and TNM stages (P < 0.01). Our data suggest that TFF3 and survivin expressions play a vital role in gastric cancer development, and these two proteins are important markers for prognosis in gastric cancer. Patients with gastric cancer can increase the survival rate through an earlier diagnosis and appropriate treatment.
KeywordsGastric cancer Immunohistochemical staining TFF3 Survivin Prognosis Survival analysis
This research was supported by the funding (Z07020) from the Bureau of Science and Technology of Zhangzhou City, China.
Conflict of interest
- 1.Muskett FW, May FE, Westley BR, Feeney J (2003) Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. Biochemistry-Us 42:15139–15147CrossRefGoogle Scholar
- 4.Efstathiou JA, Noda M, Rowan A, Dixon C, Chinery R, Jawhari A, Hattori T, Wright NA, Bodmer WF, Pignatelli M (1998) Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci 95:3122–3127PubMedCrossRefGoogle Scholar
- 13.Anti-Cancer AoC (1999) Diagnosis rules for new common malignant tumors. Peking Union Medicai College Press, BeijingGoogle Scholar
- 14.Tang ZH, Chen HS, Zou ZK, Cai SB, Su HY, Shen HW, We WQ, Lin L, Wang YH (2008) Trefoil factor 4 and CD147 expression in carninogenesis of gastric mucosa and their correlation with angiogenesis. World Chin J Digestol 16:3631–3636Google Scholar
- 16.Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, May FE, Gao J, Meitner PA, Tavares R, Resnick MB (2008) Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res 14:4161–4167PubMedCrossRefGoogle Scholar